Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-56,735
Closed -$1.03M 34
2022
Q3
$1.03M Buy
56,735
+1,411
+3% +$61.1K 0.27% 30
2022
Q2
$2.85M Buy
55,324
+17,000
+44% +$881K 0.64% 29
2022
Q1
$2.82M Buy
38,324
+24,978
+187% +$2.23M 0.61% 34
2021
Q4
$1.91M Buy
13,346
+2,302
+21% +$396K 0.45% 32
2021
Q3
$2.29M Sell
11,044
-2,582
-19% -$569K 0.46% 29
2021
Q2
$2.89M Buy
+13,626
New +$2.5M 0.51% 35
2021
Q1
Sell
-11,500
Closed -$1.28M 35
2020
Q4
$1.28M Buy
+11,500
New +$1.22M 0.24% 29

Other funds holding NVAX

Sector Gamma AS's NVAX Position: Q4 2022 in Review

Sector Gamma AS sold out of Novavax (NVAX) in Q4 2022, closing a stake of 56,735 shares — an estimated $1.03M sold.

Sector Gamma AS first reported a position in NVAX in Q4 2020 and held it in 7 quarters. The position peaked at $2.89M in Q2 2021. 252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

  • Sector Gamma AS reported no remaining Novavax position as of Q4 2022 after selling out during the quarter.
  • Sector Gamma AS sold 56,735 Novavax shares in Q4 2022, an estimated $1.03M.
  • Sector Gamma AS first reported a position in Novavax in Q4 2020 and held it in 7 quarters.
  • Sector Gamma AS's Novavax position peaked at $2.89M in Q2 2021.
  • 252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on Sector Gamma AS's 13F filing for Q4 2022, filed 7 Feb 2023.